According to a study by Future Market Insights (FMI), the pharmaceutical unit dose packaging market is expected to experience a shift in the way it operates as manufacturers focus on increasing productivity through automation system integration. According to the report, the market will exceed $26.1 billion by 2021 and record double-digit YoY growth between 2020 and 2021.
A dynamic shift from manual to automatic packaging lines, in turn, is expected to be a cost-effective proposition in the long run by increasing process efficiency and reducing reliance on manpower. The growing demand for prefilled syringes for vaccination programs is expected to be a key trend that will positively impact the pharmaceutical unit dose packaging market.
To stay ‘ahead’ of your competitors , request a sample at https://www.futuremarketinsights.com/reports/sample/rep-gb-5236.
Automated packaging lines are also capable of multitasking, handling multiple stages of the packaging process, such as forming, filling, sealing and labeling, in a single step. Designers of packaging line automation systems prioritize human-machine interface (HMI) design to streamline processes. This improved HMI can make it simpler for operators and managers to access information related to a specific packaging production line.
The above trend is expected to be supported by the increasing availability of biotech products with specific requirements for packaging such as prefilled syringes and disposable vials. Vials and prefilled syringes are the two most common forms of pharmaceutical unit dose packaging that are generally preferred in clinical research and diagnostic centers.
Vials and blisters have been identified as the most prominently used products in the pharmaceutical unit dose packaging market. Manufacturers are running strong vial production facilities in anticipation of demand for global COVID-19 vaccine supplies. Therefore, the segment is expected to expand 5.7 times its present value during the forecast period.
Key implications of the pharmaceutical unit dose packaging market
- Pharmaceutical unit dose packaging sales will surge at a CAGR of 14.7% between 2021 and 2031.
- The presence of several major players allowed the US to account for more than 87% of North American sales in 2021.
- Increase in R&D initiatives to enable the UK to grow more than 15% year-over-year in 2021
- Soaring health spending is fueling demand in Germany and France.
- Growing demand for vaccination with COVID-19 boosts sales in China, Japan and South Korea
For information on the research approach used in the report, please contact our analyst at
“Some of the leaders are aiming to strengthen their production facilities to meet the growing demand for vials and prefilled syringes to help with COVID-19 immunization,” said an FMI analyst.
Pharmaceutical Unit Capacity Packaging Market Players Focused on Geographical Expansion
According to FMI analysis, some of the major manufacturing companies in the pharmaceutical industry are targeting expansion, especially in remote areas where medical needs are not being met. The demand for small packaging solutions such as blisters is quite high in this region. In addition, drug unit dose delivery strategies include using bulk repackaging systems and some manual repackaging machines to take some medications in bulk and repackage them into single or unit doses.
Cost savings are a major benefit of topically repackaging pharmaceuticals into unit doses using high-volume automated repackaging systems. Unit Dose Solutions, Inc., Safecor Health, and Almac Group are active participants in repackaging services.
For information on the research approach used in the report, request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-5236
Impact of COVID-19 on the pharmaceutical unit dose packaging market
The global pharmaceutical unit dose packaging market is expected to witness impressive growth amid the rise of the second wave of the COVID-19 pandemic. This is mainly due to the strong demand for pharmaceuticals, pharmaceuticals and vaccines from diagnostic centers, hospitals and other healthcare institutions, which constitute the major consumers of unit dose packaging for pharmaceuticals.
Blisters and vials will continue to attract significant investment from investors in oral and injectable pharmaceutical unit dose packaging end uses. According to FMI analysis, global adoption of unit-dose packaging for pharmaceuticals will surge nearly 3.0-fold during 2021-2031.
QR codes and RFID tags are already being used by pharmaceutical unit-dose packaging manufacturers to ensure safe transportation of vaccines. The market is witnessing rapid growth in the use of automation and robotics. Pfizer, Inc., for example, has adopted a new technology to package doses of vaccine to be shipped from the United States. It is called “Ecoplat Plus” in ROBOPAC USA. This is a turntable with state-of-the-art technology that uses stretch film, wrapping turntables to ensure increased efficiency due to durability, strength and ease of use, including optimum safety of the product.
Pharmaceutical Unit Capacity Packaging Market Landscape
UDG Healthcare plc, West Pharmaceutical Services, Inc., Schott AG, SGD SA, Stevanato Group Spa, Klockner Pentaplast Group, Amcor plc, Gerresheimer AG, Berry Global, Inc., Comar LLC, Constantia Flexibles Group GmbH, Nipro Corporation, Catalent, Inc., Becton, Dickinson and Company, Adelphi Healthcare Packaging, Winpak Ltd., Pacific Vial Manufacturing Inc., Sonoco Products Company, WestRock Company, and AptarGroup, Inc. are the major players in the pharmaceutical unit dose packaging market. Tier 3 players of the market share 75-85% of the global pharmaceutical unit dose packaging market. In conclusion, major players contribute nearly 15-25% of global demand.